The CCOPER trial - Version 1.0

• Research type

  Research Study

• Full title

  A mixed-methods randomised feasibility trial comparing a collaborative care model with standard care in people with musculoskeletal and co-existing mental health conditions.

• IRAS ID

  301463

• Contact name

  Parashar Ramanuj

• Contact email

  p.ramanuj@nhs.net

• Sponsor organisation

  Royal National Orthopaedic Hospital NHS Trust

• Duration of Study in the UK

  1 years, 0 months, 1 days

• Research summary

  This study aims to support patients with a musculoskeletal and co-existing mental health condition, via implementation of the Collaborative Care Model (which will offered as the study intervention). It will be conducted as a feasibility trial to help identify what is important for a future study on a larger scale.
  
  In England, one in six adults suffer from a mental health condition, such as anxiety or depression. Despite these high numbers, mental health conditions are often unrecognised in physical healthcare settings, including patients with musculoskeletal (MSK) conditions. Patients with both a physical and mental health diagnosis are likely more difficult to treat in comparison to those with just a physical health condition.

  The Collaborative Care Model offers an alternative way of improving musculoskeletal rehabilitation as it takes into consideration both physical and mental health needs. This model involves physical and mental healthcare professionals working together to better identify and manage people with both conditions. Patients are then further supported by a Case Manager who coordinates access to relevant professionals/services following an assessment of both physical and mental health needs.

  We propose a feasibility study to assess whether the collaborative care model is beneficial to orthopaedic patients in addressing both physical and mental health needs.

  Patients over 18 years old, with an MSK condition attending therapy services at the Royal National Orthopaedic Hospital with a moderate to severe anxiety or depression score, may be eligible. Following informed consent, they will be randomly allocated to either treatment as usual or the intervention group (the collaborative care model with input from a Case Manager). All participants will participate for 6 months with a follow-up at 3 and 6 months.
  

• REC name

  London - Bloomsbury Research Ethics Committee

• REC reference

  21/LO/0594

• Date of REC Opinion

  3 Sep 2021

• REC opinion

  Unfavourable Opinion